Safety and Tolerability Study for Age-Related Macular Degeneration
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Phase 1: The purpose of this study is to evaluate the safety and tolerability of single
ascending doses of hI-con1™ for subjects with Age-Related Macular Degeneration.
Phase 2: The purpose of this study is to evaluate the safety of 3 injections of hI-con1™ at 2
different dose levels.